Purpose Dual Treatment Spf 10 87033-2000
Generic: Octinoxate 7.5%, Octisalate 5%, Oxybenzone 3%
Product NDC
87033-2000- Manufacturer
- Elysium Consumer Healthcare Llc
- Dosage Form
- Lotion
- Route
- Topical
- Product Type
- Human Otc Drug
- Marketing Start
- August 29, 2025
- Listing Expires
- December 31, 2026
- Application
- M020
Active Ingredients
| Ingredient | Strength |
|---|---|
| Octinoxate | 7.5 g/100g |
| Octisalate | 5 g/100g |
| Oxybenzone | 3 g/100g |
Packaging Options(1)
1 BOTTLE, PLASTIC in 1 CARTON (87033-2000-1) / 113 g in 1 BOTTLE, PLASTIC